Articles tagged with “cancer-drug-access”

Project Orbis Impact: Analysis of Cancer Drug Review Times

Examine Project Orbis data on FDA oncology approvals. Analysis shows concurrent review reduced submission gaps to 33 days and accelerated access by 2.6 months.

25 min read

2/28/2026

project orbis fda oncology regulatory affairs drug approval timeline concurrent submission global regulatory strategy cancer drug access swissmedic data